Sence Competitors

CloudSense is the AI-powered CPQ solution built for telecoms. Part of the TelcoDR portfolio, CloudSense helps Communication Service Providers simplify complex product configuration, accelerate quoting, and automate fulfilment across enterprise, consumer, and wholesale segments. Built on the Salesforce platform and trusted by leading operators worldwide, CloudSense supports modern telco workflows with TM Forum-certified APIs and embedded AI capabilities. Whether you’re launching new offerings, upgrading existing services, or scaling across markets, CloudSense gives you the tools to move faster and sell smarter. Learn more at www.cloudsense.com.

Established in 1992, Geosense Ltd is one of Europe’s leading manufacturers and suppliers of instruments to the geotechnical, civil engineering, mining and environmental industries. Geosense products are used globally in major projects in more than 68 countries. With a comprehensive in-house design and manufacturing capability, we can provide products not only to tight deadlines but also to suit custom-engineered solutions for specific project requirements. Geosense specialises in the manufacture of vibrating wire and MEMS sensors, which are used to produce a wide range of instruments. In addition we manufacture automated data acquisition systems to complement our sensors, including wireless systems.

WaveSense is the leader in targeted cell isolation and enrichment from liquid biopsies. WaveSense is the developer of the only FDA-registered in vitro diagnostic (IVD) devices for targeted cell isolation and enrichment. The sensitivity of this patented platform technology enables major cancer centers, laboratories, diagnostic equipment manufacturers and pharmaceutical companies worldwide to achieve significantly more reliable and accurate diagnostic results. WaveSense's in vitro diagnostic (IVD) products provide the most sensitive targeted cell enrichment solution, requiring only a small specimen to deliver the maximum number of pure target cells while simultaneously eliminating background cells. Without the need for expensive capital equipment, WaveSense technology enables enhanced patient diagnostic and management outcomes by optimizing the results of downstream diagnostic modalities including IHC, FISH, PCR, SNP, Gene Expression and NGS.